IKZF1 and hepatocellular carcinoma: Ikaros not only repressed CD133 expression, but also decreased the proportion of CD133+ HCC cells upon forced Ikaros expression (Huh7 cells for around 28.1%; PLC/PRF/5 cells for around 83.2%) (Figure 5C).